Abstract
The 6th Annual Vaccines: All Things Considered conference was hosted by GTCbio. The purpose of the conference was to provide a forum for researchers from academia, industry and government to update one another about novel vaccine developments, regulatory perspectives, new technologies and government policies. The meeting was attended by approximately 80 delegates, many from European countries, and included two keynote addresses, 20 oral presentations and 15 posters presented over a 2-day period. As part of the conference’s tradition, two posters were selected for oral presentation. This meeting report will highlight the main issues discussed.
Financial & competing interests disclosure
Wangxue Chen was an invited speaker at the conference whose registration fee was waived. The authors’ research was supported by grants from NIH (R21AI59064) and Dow AgroSciences. There are no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or material disclosed in the manuscript.
No writing assistance was utilized in the production of this manuscript.